Organismal roles for the PI3Kα and β isoforms: their specificity, redundancy or cooperation is context-dependent
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Organismal roles for the PI3Kα and β isoforms: their specificity, redundancy or cooperation is context-dependent
Authors
Keywords
-
Journal
BIOCHEMICAL JOURNAL
Volume 478, Issue 6, Pages 1199-1225
Publisher
Portland Press Ltd.
Online
2021-03-20
DOI
10.1042/bcj20210004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nuclear upregulation of class I phosphoinositide 3-kinase p110β correlates with high 47S rRNA levels in cancer cells
- (2021) Fatemeh Mazloumi Gavgani et al. JOURNAL OF CELL SCIENCE
- PI3Kβ-Regulated Pericyte Maturation Governs Vascular Remodeling
- (2020) Ana M. Figueiredo et al. CIRCULATION
- Combined targeting of G protein‐coupled receptor and EGF receptor signaling overcomes resistance to PI 3K pathway inhibitors in PTEN ‐null triple negative breast cancer
- (2020) Davide Zecchin et al. EMBO Molecular Medicine
- Inactivation of endothelial cell phosphoinositide 3-kinase β inhibits tumor angiogenesis and tumor growth
- (2020) Abul K. Azad et al. ONCOGENE
- A Single Discrete Rab5 Binding Site in PI3Kβ is Required for Tumor Cell Invasion
- (2019) Samantha D Heitz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial
- (2019) Panagiotis A Konstantinopoulos et al. LANCET ONCOLOGY
- A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB)
- (2019) Ingrid A. Mayer et al. CLINICAL CANCER RESEARCH
- Insulin-Driven PI3K-AKT Signaling in the Hepatocyte Is Mediated by Redundant PI3Kα and PI3Kβ Activities and Is Promoted by RAS
- (2019) Angela Molinaro et al. Cell Metabolism
- Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer
- (2019) Fabrice André et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular profiling establishes genetic features predictive of the efficacy of the p110β inhibitor KIN-193
- (2019) Isha Sethi et al. CANCER RESEARCH
- Tumor-intrinsic PIK3CA represses tumor immunogenicity in a model of pancreatic cancer
- (2019) Nithya Sivaram et al. JOURNAL OF CLINICAL INVESTIGATION
- Enhanced β-adrenergic signalling underlies an age-dependent beneficial metabolic effect of PI3K p110α inactivation in adipose tissue
- (2019) Caroline Araiz et al. Nature Communications
- Role of p110a subunit of PI3-kinase in skeletal muscle mitochondrial homeostasis and metabolism
- (2019) Mengyao Ella Li et al. Nature Communications
- A Systematic Literature Review Of The Prognostic And Predictive Value Of Pik3ca Mutations In Hr+/Her2–Metastatic Breast Cancer
- (2019) Lea E. Mollon et al. Clinical Breast Cancer
- PI3Kβ is selectively required for growth factor-stimulated macropinocytosis
- (2019) Gilbert Salloum et al. JOURNAL OF CELL SCIENCE
- How is the acyl chain composition of phosphoinositides created and does it matter?
- (2019) David Barneda et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- A Phase Ib Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity-Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma
- (2019) Lara A. Dunn et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
- (2019) Neil Vasan et al. SCIENCE
- Increased fatty acyl saturation of phosphatidylinositol phosphates in prostate cancer progression
- (2019) Atsushi Koizumi et al. Scientific Reports
- The Hippo pathway integrates PI3K–Akt signals with mechanical and polarity cues to control tissue growth
- (2019) Nerea Borreguero-Muñoz et al. PLOS BIOLOGY
- Profiling of phosphoinositide molecular species in human and mouse platelets identifies new species increasing following stimulation
- (2018) Abdulrahman Mujalli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Phase I study of alpelisib (BYL-719) and trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer (MBC) after trastuzumab and taxane therapy
- (2018) Sarika Jain et al. BREAST CANCER RESEARCH AND TREATMENT
- A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer
- (2018) Autumn J. McRee et al. Clinical Breast Cancer
- Functional Analysis of Promoters from Three Subtypes of the PI3K Family and Their Roles in the Regulation of Lipid Metabolism by Insulin in Yellow Catfish Pelteobagrus fulvidraco
- (2018) Mei-Qin Zhuo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important?
- (2018) Célia Cintas et al. Frontiers in Oncology
- Impact of PI3Kα (Phosphoinositide 3-Kinase Alpha) Inhibition on Hemostasis and Thrombosis
- (2018) Pierre-Alexandre Laurent et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Clinical and biomarker results from phase I/II study of PI3K inhibitor BYL 719 (alpelisib) plus nab-paclitaxel in HER2-negative metastatic breast cancer.
- (2018) Priyanka Sharma et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined inhibition of PI3Kβ and mTOR inhibits growth of PTEN null tumours
- (2018) James T Lynch et al. MOLECULAR CANCER THERAPEUTICS
- Structural Basis for Regulation of Phosphoinositide Kinases and Their Involvement in Human Disease
- (2018) John E. Burke MOLECULAR CELL
- Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
- (2018) Benjamin D. Hopkins et al. NATURE
- Targeted therapy in patients with PIK3CA-related overgrowth syndrome
- (2018) Quitterie Venot et al. NATURE
- Cancer-Associated PIK3CA Mutations in Overgrowth Disorders
- (2018) Ralitsa R. Madsen et al. TRENDS IN MOLECULAR MEDICINE
- A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors
- (2018) Jordi Rodon et al. Oncotarget
- Endothelial and cardiomyocyte PI3Kβ divergently regulate cardiac remodelling in response to ischaemic injury
- (2018) Xueyi Chen et al. CARDIOVASCULAR RESEARCH
- Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine
- (2018) James RW Conway et al. GUT
- Quantitation of class IA PI3Ks in mice reveals p110-free-p85s and isoform-selective subunit associations and recruitment to receptors
- (2018) N. Tsolakos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Endothelial cell rearrangements during vascular patterning require PI3-kinase-mediated inhibition of actomyosin contractility
- (2018) Ana Angulo-Urarte et al. Nature Communications
- PI3Kα-regulated gelsolin activity is a critical determinant of cardiac cytoskeletal remodeling and heart disease
- (2018) Vaibhav B. Patel et al. Nature Communications
- Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma
- (2017) Olca Basturk et al. MODERN PATHOLOGY
- Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial–mesenchymal transition through the regulation of ADAM10 and ADAM17
- (2017) Ga Bin Park et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The acyltransferase LYCAT controls specific phosphoinositides and related membrane traffic
- (2017) Leslie N. Bone et al. MOLECULAR BIOLOGY OF THE CELL
- TGX-221 inhibits proliferation and induces apoptosis in human glioblastoma cells
- (2017) Xue Yang et al. ONCOLOGY REPORTS
- Improving the Armamentarium of PI3K Inhibitors with Isoform-Selective Agents: A New Light in the Darkness
- (2017) Jordi Rodon et al. Cancer Discovery
- A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic BRAF -Mutant Colorectal Cancer
- (2017) Robin M.J.M. van Geel et al. Cancer Discovery
- AACR Project GENIE: Powering Precision Medicine through an International Consortium
- (2017) Cancer Discovery
- Loss of PI3K p110α in the Adipose Tissue Results in Infertility and Delayed Puberty Onset in Male Mice
- (2017) Victoria L. Boughton Nelson et al. Biomed Research International
- Suppression of CD4+ T Lymphocyte Activation in Vitro and Experimental Encephalomyelitis in Vivo by the Phosphatidyl Inositol 3-Kinase Inhibitor PIK-75
- (2017) Y.Y. Acosta et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Ph IB study of LEE011 and BYL719 in combination with letrozole in ER+, HER2- breast cancer.
- (2017) Pamela N. Munster et al. JOURNAL OF CLINICAL ONCOLOGY
- PI3Kα inhibition reduces obesity in mice
- (2016) Elena Lopez-Guadamillas et al. Aging-US
- Emerging evidence of signalling roles for PI(3,4)P2 in Class I and II PI3K-regulated pathways
- (2016) P. T. Hawkins et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Abstract CT061: A phase Ib study of alpelisib (BYL719) + everolimus ± exemestane in patients with advanced solid tumors or HR+/HER2-breast cancer
- (2016) Jose Baselga et al. CANCER RESEARCH
- GPCR Signaling Mediates Tumor Metastasis via PI3K
- (2016) B. D. Khalil et al. CANCER RESEARCH
- Activating Mutations in PIK3CB Confer Resistance to PI3K Inhibition and Define a Novel Oncogenic Role for p110
- (2016) Y. Nakanishi et al. CANCER RESEARCH
- Combined Inhibition of Both p110α and p110β Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER + Breast Cancer
- (2016) Sarah R. Hosford et al. CLINICAL CANCER RESEARCH
- Therapeutic Benefit of Selective Inhibition of p110 PI3-Kinase in Pancreatic Neuroendocrine Tumors
- (2016) A. Soler et al. CLINICAL CANCER RESEARCH
- The Phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3) Binder Rasa3 Regulates Phosphoinositide 3-kinase (PI3K)-dependent Integrin αIIbβ3Outside-in Signaling
- (2016) Anthony M. Battram et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Coincident signals from GPCRs and receptor tyrosine kinases are uniquely transduced by PI3Kβ in myeloid cells
- (2016) Daniel M. Houslay et al. Science Signaling
- Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans
- (2016) Sandra D. Castillo et al. Science Translational Medicine
- Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
- (2016) Yujun Hao et al. Nature Communications
- E-cadherin downregulation sensitizes PTEN-mutant tumors to PI3Kβ silencing
- (2016) África Millán-Uclés et al. Oncotarget
- Rac1-mediated membrane raft localization of PI3K/p110β is required for its activation by GPCRs or PTEN loss
- (2016) Onur Cizmecioglu et al. eLife
- Coincident signals from GPCRs and receptor tyrosine kinases are uniquely transduced by PI3Kβ in myeloid cells
- (2016) Daniel M. Houslay et al. Science Signaling
- Inhibition of class IA PI3K enzymes in non-small cell lung cancer cells uncovers functional compensation among isoforms
- (2015) Christopher Stamatkin et al. CANCER BIOLOGY & THERAPY
- Measurement of PIP3 Levels Reveals an Unexpected Role for p110β in Early Adaptive Responses to p110α-Specific Inhibitors in Luminal Breast Cancer
- (2015) Carlotta Costa et al. CANCER CELL
- Feedback Suppression of PI3Kα Signaling in PTEN-Mutated Tumors Is Relieved by Selective Inhibition of PI3Kβ
- (2015) Sarit Schwartz et al. CANCER CELL
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Pharmacological Inhibition of PI3K Reduces Adiposity and Metabolic Syndrome in Obese Mice and Rhesus Monkeys
- (2015) Ana Ortega-Molina et al. Cell Metabolism
- RASA3 is a critical inhibitor of RAP1-dependent platelet activation
- (2015) Lucia Stefanini et al. JOURNAL OF CLINICAL INVESTIGATION
- Exploration of efficacy and bleeding with combined phosphoinositide 3-kinase β inhibition and aspirin in man
- (2015) S. Nylander et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
- (2015) Christophe Le Tourneau et al. LANCET ONCOLOGY
- PTEN Functions by Recruitment to Cytoplasmic Vesicles
- (2015) Adam Naguib et al. MOLECULAR CELL
- Perturbations of PIP3 signalling trigger a global remodelling of mRNA landscape and reveal a transcriptional feedback loop
- (2015) Vladimir Yu. Kiselev et al. NUCLEIC ACIDS RESEARCH
- Oncogenic activation of the PI3-kinase p110β isoform via the tumor-derived PIK3CβD1067V kinase domain mutation
- (2015) E Pazarentzos et al. ONCOGENE
- PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer
- (2015) Ana Bosch et al. Science Translational Medicine
- p53 attenuates AKT signaling by modulating membrane phospholipid composition
- (2015) Natalia Rueda-Rincon et al. Oncotarget
- P53 Mutations Change Phosphatidylinositol Acyl Chain Composition
- (2015) Adam Naguib et al. Cell Reports
- Novel Role for p110β PI 3-Kinase in Male Fertility through Regulation of Androgen Receptor Activity in Sertoli Cells
- (2015) Julie Guillermet-Guibert et al. PLoS Genetics
- Regulation of the PI3K pathway through a p85α monomer–homodimer equilibrium
- (2015) Lydia WT Cheung et al. eLife
- Inhibitors of pan-PI3K Signaling Synergize with BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth
- (2015) Melanie Sweetlove et al. Frontiers in Oncology
- A beta version of life: p110β takes center stage
- (2015) Oncotarget
- Adipose tissue insulin resistance due to loss of PI3K p110α leads to decreased energy expenditure and obesity
- (2014) Victoria L. B. Nelson et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Phosphoinositide 3-Kinases p110α and p110β Have Differential Roles in Insulin-Like Growth Factor-1–Mediated Akt Phosphorylation and Platelet Priming
- (2014) Thomas A. Blair et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Platelet PI3K and GSK3 regulate thrombus stability at a high shear rate
- (2014) P.-A. Laurent et al. BLOOD
- PI3KCA plays a major role in multiple myeloma and its inhibition with BYL719 decreases proliferation, synergizes with other therapies and overcomes stroma-induced resistance
- (2014) Feda Azab et al. BRITISH JOURNAL OF HAEMATOLOGY
- PI3K Regulation of RAC1 Is Required for KRAS-Induced Pancreatic Tumorigenesis in Mice
- (2014) Chia-Yen C. Wu et al. GASTROENTEROLOGY
- Pancreatic cell plasticity and cancer initiation induced by oncogenic Kras is completely dependent on wild-type PI 3-kinase p110α
- (2014) Romain Baer et al. GENES & DEVELOPMENT
- Hematopoiesis and RAS-driven myeloid leukemia differentially require PI3K isoform p110α
- (2014) Kira Gritsman et al. JOURNAL OF CLINICAL INVESTIGATION
- ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism
- (2014) Yanan Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- The Phosphoinositide 3-Kinase Selective Inhibitor BYL719 Enhances the Effect of the Protein Kinase C Inhibitor AEB071 in GNAQ/GNA11-Mutant Uveal Melanoma Cells
- (2014) E. Musi et al. MOLECULAR CANCER THERAPEUTICS
- Suppression of Feedback Loops Mediated by PI3K/mTOR Induces Multiple Overactivation of Compensatory Pathways: An Unintended Consequence Leading to Drug Resistance
- (2014) E. Rozengurt et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of PI3K Signaling with AZD8186 Inhibits Growth of PTEN-Deficient Breast and Prostate Tumors Alone and in Combination with Docetaxel
- (2014) U. Hancox et al. MOLECULAR CANCER THERAPEUTICS
- Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor
- (2014) Dejan Juric et al. NATURE
- Discovery and saturation analysis of cancer genes across 21 tumour types
- (2014) Michael S. Lawrence et al. NATURE
- PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
- (2014) Ajay K. Gopal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting Class IA PI3K Isoforms Selectively Impairs Cell Growth, Survival, and Migration in Glioblastoma
- (2014) Katrin Höland et al. PLoS One
- PI3K isoform dependence of PTEN-deficient tumors can be altered by the genetic context
- (2014) F. Schmit et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FOXO transcription factors: key regulators of cellular quality control
- (2014) Ashley E. Webb et al. TRENDS IN BIOCHEMICAL SCIENCES
- Physiological expression of the PI3K-activating mutationPik3caH1047Rcombines withApcloss to promote development of invasive intestinal adenocarcinomas in mice
- (2013) Lauren M. Hare et al. BIOCHEMICAL JOURNAL
- Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription
- (2013) D. Thomas et al. BLOOD
- Requirement for Interaction of PI3-Kinase p110α with RAS in Lung Tumor Maintenance
- (2013) Esther Castellano et al. CANCER CELL
- RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms
- (2013) Ralph Fritsch et al. CELL
- Long-term p110α PI3K inactivation exerts a beneficial effect on metabolism
- (2013) Lazaros C. Foukas et al. EMBO Molecular Medicine
- Spatially distinct roles of class Ia PI3K isoforms in the development and maintenance of PTEN hamartoma tumor syndrome
- (2013) Q. Wang et al. GENES & DEVELOPMENT
- Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine
- (2013) HONG-QUAN DUONG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis
- (2013) Adriana Soler et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Class IA PI3K p110β Subunit Promotes Autophagy through Rab5 Small GTPase in Response to Growth Factor Limitation
- (2013) Zhixun Dou et al. MOLECULAR CELL
- Development of PI3K inhibitors: lessons learned from early clinical trials
- (2013) Jordi Rodon et al. Nature Reviews Clinical Oncology
- PIK3CA and APC mutations are synergistic in the development of intestinal cancers
- (2013) D A Deming et al. ONCOGENE
- Characterization of a Tumor-Associated Activating Mutation of the p110β PI 3-Kinase
- (2013) Hashem A. Dbouk et al. PLoS One
- Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies
- (2013) A. B. Hanker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Isoform-selective induction of human p110δ PI3K expression by TNFα: identification of a new and induciblePIK3CDpromoter
- (2012) Maria A. Whitehead et al. BIOCHEMICAL JOURNAL
- The p110 and p110 isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis
- (2012) T. Utermark et al. GENES & DEVELOPMENT
- An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice
- (2012) Kathryn M. Kinross et al. JOURNAL OF CLINICAL INVESTIGATION
- Human target validation of phosphoinositide 3-kinase (PI3K)β: effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kβ inhibitor
- (2012) S. NYLANDER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- LPIAT1 regulates arachidonic acid content in phosphatidylinositol and is required for cortical lamination in mice
- (2012) Hyeon-Cheol Lee et al. MOLECULAR BIOLOGY OF THE CELL
- Conditional activation of Pik3ca H1047R in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations
- (2012) W Yuan et al. ONCOGENE
- G Protein-Coupled Receptor-Mediated Activation of p110 by G Is Required for Cellular Transformation and Invasiveness
- (2012) H. A. Dbouk et al. Science Signaling
- Opposing Effects of Androgen Deprivation and Targeted Therapy on Prostate Cancer Prevention
- (2012) Shidong Jia et al. Cancer Discovery
- Both p110α and p110β isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressor
- (2011) Inma M. Berenjeno et al. BIOCHEMICAL JOURNAL
- Effects of acutely inhibiting PI3K isoforms and mTOR on regulation of glucose metabolismin vivo
- (2011) Greg C. Smith et al. BIOCHEMICAL JOURNAL
- Role and regulation of phosphatidylinositol 3-kinase in platelet integrin 2 1 signaling
- (2011) A. Consonni et al. BLOOD
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
- (2011) Brett S. Carver et al. CANCER CELL
- Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
- (2011) J. R. Adams et al. CANCER RESEARCH
- Luminal Expression of PIK3CA Mutant H1047R in the Mammary Gland Induces Heterogeneous Tumors
- (2011) D. S. Meyer et al. CANCER RESEARCH
- Nuclear but Not Cytosolic Phosphoinositide 3-Kinase Beta Has an Essential Function in Cell Survival
- (2011) A. Kumar et al. MOLECULAR AND CELLULAR BIOLOGY
- Structure of Lipid Kinase p110β/p85β Elucidates an Unusual SH2-Domain-Mediated Inhibitory Mechanism
- (2011) Xuxiao Zhang et al. MOLECULAR CELL
- Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway–dependent and PI3K pathway–independent mechanisms
- (2011) Pixu Liu et al. NATURE MEDICINE
- Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases
- (2011) Oscar Vadas et al. Science Signaling
- PI3K Plays a Critical Role in Neutrophil Activation by Immune Complexes
- (2011) S. Kulkarni et al. Science Signaling
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
- (2011) Michelle C. Mendoza et al. TRENDS IN BIOCHEMICAL SCIENCES
- Deletion of the p110 isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivo
- (2010) V. Martin et al. BLOOD
- Specific Roles of the p110α Isoform of Phosphatidylinsositol 3-Kinase in Hepatic Insulin Signaling and Metabolic Regulation
- (2010) Victoria Rotter Sopasakis et al. Cell Metabolism
- Essential Role of the p110β Subunit of Phosphoinositide 3-OH Kinase in Male Fertility
- (2010) Elisa Ciraolo et al. MOLECULAR BIOLOGY OF THE CELL
- Diverse somatic mutation patterns and pathway alterations in human cancers
- (2010) Zhengyan Kan et al. NATURE
- The emerging mechanisms of isoform-specific PI3K signalling
- (2010) Bart Vanhaesebroeck et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A biochemical mechanism for the oncogenic potential of the p110 catalytic subunit of phosphoinositide 3-kinase
- (2010) H. A. Dbouk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activity of any class IA PI3K isoform can sustain cell proliferation and survival
- (2010) L. C. Foukas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A constitutively activated form of the p110 isoform of PI3-kinase induces prostatic intraepithelial neoplasia in mice
- (2010) S. H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PIKing the right isoform: the emergent role of the p110β subunit in breast cancer
- (2010) Silvia Carvalho et al. VIRCHOWS ARCHIV
- Genetic evidence for a predominant role of PI3K catalytic activity in ITAM- and integrin-mediated signaling in platelets
- (2009) I. Canobbio et al. BLOOD
- AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer
- (2009) Krishna M. Vasudevan et al. CANCER CELL
- Dominant Role of the p110β Isoform of PI3K over p110α in Energy Homeostasis Regulation by POMC and AgRP Neurons
- (2009) Hind Al-Qassab et al. Cell Metabolism
- Specific function of phosphoinositide 3-kinase beta in the control of DNA replication
- (2009) M. Marques et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of phosphoinositide 3-kinase expression in health and disease
- (2009) Klaartje Kok et al. TRENDS IN BIOCHEMICAL SCIENCES
- Phosphoinositide 3-Kinases p110 and p110 Regulate Cell Cycle Entry, Exhibiting Distinct Activation Kinetics in G1 Phase
- (2008) M. Marques et al. MOLECULAR AND CELLULAR BIOLOGY
- Angiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration
- (2008) Mariona Graupera et al. NATURE
- Essential roles of PI(3)K–p110β in cell growth, metabolism and tumorigenesis
- (2008) Shidong Jia et al. NATURE
- Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
- (2008) Jeffrey A Engelman et al. NATURE MEDICINE
- Phosphoinositide 3-OH kinase p85α and p110β are essential for androgen receptor transactivation and tumor progression in prostate cancers
- (2008) Q Zhu et al. ONCOGENE
- The p110 isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110
- (2008) J. Guillermet-Guibert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PTEN-deficient cancers depend on PIK3CB
- (2008) S. Wee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phosphoinositide 3-Kinase p110 Activity: Key Role in Metabolism and Mammary Gland Cancer but Not Development
- (2008) E. Ciraolo et al. Science Signaling
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now